Shengtai Pharmaceutical, Inc. reported that its revenues climbed 76% in fiscal 2008 (ended June 30) to $91 million. Net Income was up 46% to $10.4 million. Shengtai makes and distributes pharmaceutical grade glucose products in China, as well as glucose and other products for the food and beverage industry. According to the company, the increased revenues and earnings were the result of a two-year investment program that integrated the company vertically and increased its production capacity. More details...
Stock Symbol: (OTCBB: SGTI)